Walgreens Boots Non-GAAP EPS of $1.16 beats by $0.05, revenue of $34.9B beats by $1.34B
Walgreens Boots press release (NASDAQ:WBA): Q2 Non-GAAP EPS of $1.16  beats by $0.05.
Revenue of $34.9B (+7.6% Y/Y)  beats by $1.34B.
The company is maintaining full-year adjusted EPS guidance of $4.45 to $4.65 vs. consensus of $4.50, as strong core business growth is more than offset by lapping peak COVID-19 demand; pivoting to mid-twenties percent adjusted EPS growth in the second half of fiscal 2023 at the midpoint.

CEO comment: "WBA exited a solid second quarter with acceleration in February, adding to our confidence in driving strong growth in the second half of the year. With the closing of VillageMD's acquisition of Summit Health, WBA is now one of the largest players in primary care, with best-in-class assets across the care continuum. Both Walgreens and Boots are performing well by delivering compelling value to consumers, playing a critical role as community health destinations, and successfully navigating a challenging environment. We will continue to take bold actions to create sustainable long-term shareholder value."